X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $63,557.80 +2.84%
Ethereum $1,689.61 +4.44%
BNB $601.38 +2.24%
Optimism $0.10 +6.30%
Arbitrum $0.08 +3.55%
Solana $66.95 +4.57%
Polygon $0.22 +2.77%
Cosmos $1.75 +5.27%
Avalanche $6.81 +2.66%

Bitcoin $63,557.80 +2.84%
Ethereum $1,689.61 +4.44%
BNB $601.38 +2.24%
Optimism $0.10 +6.30%
Arbitrum $0.08 +3.55%
Solana $66.95 +4.57%
Polygon $0.22 +2.77%
Cosmos $1.75 +5.27%
Avalanche $6.81 +2.66%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed